Dr. Luo earned her PhD from the University of Toronto.
Dr. Luo primarily works in the field of Neuroscience and oversees all research and development in this area.
Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
